Harbour Investments’s Beta Bionics BBNX Stock Holding History

Harbour Investments’s Portfolio BBNX Stock Details BBNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.66K	Hold	106	–	–	﹤0.01%	4079
2026 Q1	$1.06K	Buy	+106	New	+$1.57K	﹤0.01%	4087

Other funds holding BBNX

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Harbour Investments's BBNX Position: Q2 2026 in Review

Harbour Investments held its Beta Bionics (BBNX) position steady in Q2 2026 at 106 shares worth $1.66K. The position accounts for ﹤0.01% of the portfolio, ranked #4079.

Harbour Investments first reported a position in BBNX in Q1 2026 and has held it in 2 quarters since. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

Harbour Investments held 106 shares of Beta Bionics worth $1.66K as of Q2 2026.
Harbour Investments left its Beta Bionics share count unchanged in Q2 2026.
Beta Bionics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4079 holding.
Harbour Investments first reported a position in Beta Bionics in Q1 2026 and has held it in 2 quarters since.
133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.